Cargando…

Liraglutide Suppresses Obesity and Hyperglycemia Associated with Increases in Hepatic Fibroblast Growth Factor 21 Production in KKA(y) Mice

Social isolation contributes to the development of obesity and insulin-independent diabetes in KKA(y) mice. Here we show that systemic administration of liraglutide, a long-acting human glucagon-like peptide-1 (GLP-1) analog, significantly decreased food intake, body weight, and blood glucose levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nonogaki, Katsunori, Hazama, Miki, Satoh, Noriko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997887/ https://www.ncbi.nlm.nih.gov/pubmed/24804243 http://dx.doi.org/10.1155/2014/751930

Ejemplares similares

Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKA(y) mice
por: Nonogaki, Katsunori, et al.
Publicado: (2020)

Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKA(y) mice
por: Nonogaki, K, et al.
Publicado: (2016)

Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet
por: Nonogaki, Katsunori, et al.
Publicado: (2020)

Liraglutide Suppresses the Plasma Levels of Active and Des-Acyl Ghrelin Independently of Active Glucagon-Like Peptide-1 Levels in Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2013)

Psychometric properties of the Psychological Capital Questionnaire (KKaPsy)
por: Lipińska-Grobelny, Agnieszka, et al.
Publicado: (2022)

Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2018)

Inhibition of 11βHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKA(y )mice
por: Sundbom, Maj, et al.
Publicado: (2008)

Protective Effects of MDG-1, a Polysaccharide from Ophiopogon japonicus on Diabetic Nephropathy in Diabetic KKA(y) Mice
por: Wang, Yuan, et al.
Publicado: (2015)

Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639
por: Nonogaki, Katsunori
Publicado: (2013)

Erythropoietin suppresses hepatic steatosis and obesity by inhibiting endoplasmic reticulum stress and upregulating fibroblast growth factor 21
por: Hong, Ting, et al.
Publicado: (2019)

Cesium suppresses fibroblast proliferation and migration
por: Khatun, Ziasmin, et al.
Publicado: (2020)

FRI063 Effectiveness Of Liraglutide In Treating Obesity And Improving Hepatic Steatosis
por: Alfadda, Assim Abdulaziz, et al.
Publicado: (2023)

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
por: Xu, Jing, et al.
Publicado: (2009)

Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs
por: Xu, Pengfei, et al.
Publicado: (2016)

Low-frequency and low-intensity ultrasound increases cardiac parasympathetic neural activity and decreases clinic hypertension in elderly hypertensive subjects with type 2 diabetes
por: Nonogaki, Katsunori, et al.
Publicado: (2018)

Sasa veitchii extract reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet
por: Yoshioka, Hiroki, et al.
Publicado: (2017)

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
por: Suzuki, Keita, et al.
Publicado: (2022)

Efficacy and safety of liraglutide in Indian adolescents with obesity
por: Kochar, I. S., et al.
Publicado: (2019)

Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili, Heshma, et al.
Publicado: (2021)

Liraglutide pharmacokinetics and exposure‐response in adolescents with obesity
por: Carlsson Petri, Kristin C., et al.
Publicado: (2021)

Ingestion of whey protein and β-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice
por: Nonogaki, Katsunori, et al.
Publicado: (2023)

Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice
por: Song, Ji-Xian, et al.
Publicado: (2022)

The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases
por: Nonogaki, Katsunori
Publicado: (2022)

Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report
por: Zhang, Lei, et al.
Publicado: (2022)

Hepatic overexpression of protein targeting to glycogen attenuates obesity and improves hyperglycemia in db/db mice
por: López-Soldado, Iliana, et al.
Publicado: (2022)

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
por: Fisher, ffolliott M., et al.
Publicado: (2010)

Liraglutide and obesity: a review of the data so far
por: Ladenheim, Ellen E
Publicado: (2015)

Effects of liraglutide on obesity-associated functional hypogonadism in men
por: Jensterle, M, et al.
Publicado: (2019)

Liraglutide restores impaired associative learning in individuals with obesity
por: Hanssen, Ruth, et al.
Publicado: (2023)

Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
por: Lee, Young-Sun, et al.
Publicado: (2016)

Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets
por: Le, Thao D.V., et al.
Publicado: (2023)

Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
por: Wang, Xing, et al.
Publicado: (2021)

Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance
por: Yang, Mengliu, et al.
Publicado: (2012)

Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
por: Lin, Zhuofeng, et al.
Publicado: (2015)

Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
por: Cheng, Kai-Chun, et al.
Publicado: (2020)

Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
por: Sarruf, David A., et al.
Publicado: (2010)

Sodium Meta-Arsenite Ameliorates Hyperglycemia in Obese Diabetic db/db Mice by Inhibition of Hepatic Gluconeogenesis
por: Lee, Young-Sun, et al.
Publicado: (2014)

Low-frequency and low-intensity ultrasound irradiation to the forearm improves an index of arterial stiffness in subjects with type 2 diabetes and hypertension
por: Nonogaki, Katsunori, et al.
Publicado: (2017)

Hyperglycemia Slows Embryonic Growth and Suppresses Cell Cycle via Cyclin D1 and p21
por: Scott-Drechsel, Devon E., et al.
Publicado: (2013)

Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role in insulin resistance and obesity
por: Liang, Y, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_utp64kv00v07bb9fll2c2bth5r